Key result
Avidity ELISA may better measure protective immunity than LPBE by detecting low avidity despite strong titers.
Why the study?
The study was conducted to determine the actual status of protective antibodies generated after vaccination with inactivated foot-and-mouth disease vaccine.
Observational (n=40)
Avidity ELISA may provide a more accurate measure of protective immunity post-vaccination in FMD than traditional LPBE.
Avidity ELISA merits testing as a correlate of FMD protection in livestock; leaves open validation beyond this animal model.
In this study, forty serum samples from field buffaloes vaccinated with inactivated foot-and-mouth disease (FMD) vaccine were collected. These animals were multiple vaccinated with the above vaccine during previous years. The study was conducted to determine the actual status of the protective antibodies generated after vaccination. Initially, the serum samples were tested by Liquid phase blocking ELISA (LPBE), and only samples with titer more than 1.4 in LPBE were chosen for further analysis. These samples were tested with an in-house Gold Nanoparticle-based test for detection of anti-FMDV structural protein antibodies, in which the antibodies were detected at 10-4 dilution; this was suggestive of strong antibody titer generated post-vaccination. To test the binding affinity of these antibodies with the antigen, an avidity ELISA was developed and outcomes were expressed in terms of avidity index (AI). It was found that the avidity was low in some of the animals even after multiple vaccinations. Therefore, multiple vaccinations and strong antibody titer generation may not be the actual indicator of the protective immune response generated. We conclude that avidity ELISA can be a better approach than LPBE to measure the level of protective antibodies generated post-vaccination.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2022) conducted an observational in Foot-and-mouth disease vaccination immunity (n=40). Multiple vaccinations with inactivated FMD vaccine was evaluated on Avidity index (AI) of anti-FMDV structural protein antibodies. Avidity ELISA demonstrated low antibody avidity in some multiple-vaccinated buffaloes despite strong antibody titers, suggesting it may be a better measure of protective immunity than LPBE.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: